Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jay Wiggins is active.

Publication


Featured researches published by Jay Wiggins.


European Journal of Medicinal Chemistry | 1988

Cardiotonic agents 4. Dimaprit analogues as potential cardiovascular selective H2-agonists

Albert H. Owens; Richard Goehring; John W. Lampe; Paul W. Erhardt; William Lumma; Jay Wiggins

Abstract Several derivatives of dimaprit including carbon chain substitution, nitrogen substitution and isothiourea replacements were prepared and tested for inotropic activity in guinea pig papillary muscle preparations. Two derivatives showed moderate positive inotropic effects which were mediated by the H 2 -histaminergic pathway.


Journal of Medicinal Chemistry | 1987

Cardiotonic agents. 1. Novel 8-aryl substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents

David D. Davey; Paul W. Erhardt; William C. Lumma; Jay Wiggins; Mark E. Sullivan; David C. Pang; Elinor Cantor


Journal of Medicinal Chemistry | 1991

Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogues

David D. Davey; Paul W. Erhardt; Elinor Cantor; S. S. Greenberg; W. R. Ingebretsen; Jay Wiggins


Journal of Medicinal Chemistry | 1990

Cardiotonic agents. 6. Histamine analogues as potential cardiovascular selective H2 agonists.

John W. Lampe; Reda G. Hanna; Thomas A. Piscitelli; Yuo Ling Chou; Paul W. Erhardt; William C. Lumma; Stanley Shimen Greenberg; William R. Ingebretsen; Dennis C. Marshall; Jay Wiggins


Journal of Medicinal Chemistry | 1992

Cardiotonic agents. 7. Prodrug derivatives of 4-ethyl-1,3-dihydro- 5-[4-(2-methyl-1H-imidazol-1-yl)benzoyl]-2H-imidazol-2-one.

Kenneth J. Shaw; Paul W. Erhardt; Alfred A. Hagedom; Cynthia A. Pease; William R. Ingebretsen; Jay Wiggins


Drug Development Research | 1988

Tissue specificity of cAMP‐phosphodiesterase inhibitors: Rolipram, amrinone, milrinone, enoximone, piroximone, and imazodan

David C. Pang; Elinor Cantor; Alfred Arthur Hagedorn; Paul W. Erhardt; Jay Wiggins


Academic Radiology | 1998

Safety of Levovist injection in patients undergoing exercise stress echocardiography: A placebo-controlled study

Jay Wiggins; Ginette Jacob; Harold A. Goldstein


Investigative Radiology | 1994

NEW CLINICAL TRIAL EXPERIENCE WITH IOPROMIDE

Harold A. Goldstein; Ginette Jacob; Jay Wiggins


The Journal of Nuclear Medicine | 1991

Gallium-67/Stable Gadolinium Antagonism

Jay Wiggins; Harold A. Goldstein; Hans J. Weinmann


Academic Radiology | 2002

Electrocardiographic effects of diagnostic imaging agents

Jay Wiggins; R Beckmann; H.J Weinmann; R Lehr

Collaboration


Dive into the Jay Wiggins's collaboration.

Top Co-Authors

Avatar

Paul W. Erhardt

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Elinor Cantor

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Harold A. Goldstein

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

William C. Lumma

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

David C. Pang

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Ginette Jacob

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

John W. Lampe

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Alfred Arthur Hagedorn

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

David D. Davey

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Richard Goehring

Bayer HealthCare Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge